179 related articles for article (PubMed ID: 667419)
21. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
[TBL] [Abstract][Full Text] [Related]
22. Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats.
Irimia C; Polis IY; Stouffer D; Parsons LH
Psychopharmacology (Berl); 2015 Aug; 232(16):3033-43. PubMed ID: 25925779
[TBL] [Abstract][Full Text] [Related]
23. The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat.
Hernández-Tristán R; Arévalo C; Canals S; Leret ML
J Physiol Biochem; 2000 Mar; 56(1):17-24. PubMed ID: 10879677
[TBL] [Abstract][Full Text] [Related]
24. Neurochemical and behavioural correlates of the interaction between amphetamine and delta 9-tetrahydrocannabinol in the rat.
Lew EO; Richardson JS
Drug Alcohol Depend; 1981 Sep; 8(2):93-101. PubMed ID: 6274603
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of delta 9-tetrahydrocannabinol-induced withdrawal-like behaviour by delta 9-tetrahydrocannabinol.
Verberne AJ; Taylor DA; Fennessy MR
Psychopharmacology (Berl); 1981; 73(1):97-8. PubMed ID: 6262850
[TBL] [Abstract][Full Text] [Related]
26. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
27. Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover.
Waldmeier PC; Baumann P; Greengrass PM; Maître L
Postgrad Med J; 1976; 52(3 suppl):33-9. PubMed ID: 785423
[No Abstract] [Full Text] [Related]
28. Profound hypothermia in mammals treated with tetrahydrocannabinols, morphine, or chlorpromazine.
Haavik CO
Fed Proc; 1977 Nov; 36(12):2595-8. PubMed ID: 913617
[TBL] [Abstract][Full Text] [Related]
29. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
30. Delta9 -tetrahydrocannabinol increases brain temperature and inverts circadian rhythms.
Perron RR; Tyson RL; Sutherland GR
Neuroreport; 2001 Dec; 12(17):3791-4. PubMed ID: 11726796
[TBL] [Abstract][Full Text] [Related]
31. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.
Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D
Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821
[TBL] [Abstract][Full Text] [Related]
32. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
Freedland CS; Whitlow CT; Miller MD; Porrino LJ
Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
[TBL] [Abstract][Full Text] [Related]
33. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.
Anderson PF; Jackson DM; Chesher GB; Malor R
Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.
Hershkowitz M; Szechtman H
Eur J Pharmacol; 1979 Nov; 59(3-4):267-76. PubMed ID: 230975
[TBL] [Abstract][Full Text] [Related]
35. Stimulant actions of delta9-tetrahydrocannabinol in mice.
Evans MA; Harbison RD; Brown DJ; Forney RB
Psychopharmacology (Berl); 1976 Nov; 50(3):245-50. PubMed ID: 826969
[TBL] [Abstract][Full Text] [Related]
36. Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).
Järbe TU; Lamb RJ; Liu Q; Makriyannis A
Psychopharmacology (Berl); 2006 Oct; 188(3):315-23. PubMed ID: 16953384
[TBL] [Abstract][Full Text] [Related]
37. Delta9-tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors.
Krowicki ZK; Moerschbaecher JM; Winsauer PJ; Digavalli SV; Hornby PJ
Eur J Pharmacol; 1999 Apr; 371(2-3):187-96. PubMed ID: 10357256
[TBL] [Abstract][Full Text] [Related]
38. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Craft RM; Wakley AA; Tsutsui KT; Laggart JD
J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
[TBL] [Abstract][Full Text] [Related]
39. Tolerance to the effects of delta9-THC on shuttle-box performance and body temperature.
ten Ham M
Pharmacol Biochem Behav; 1977 Feb; 6(2):183-5. PubMed ID: 859896
[TBL] [Abstract][Full Text] [Related]
40. Effects of chlorimipramine on experimentally induced changes in forebrain 5-hydroxy-indoles.
Collard KJ; Roberts MH
Eur J Pharmacol; 1974 Nov; 29(1):154-60. PubMed ID: 4435036
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
